Stay updated on Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.

Latest updates to the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.7.0 is now displayed, replacing the previous v3.6.6 tag. This indicates a background UI update without altering the study information presented on the page.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page's revision identifier was updated from v3.6.5 to v3.6.6, signaling a small update to the page metadata.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page's revision metadata was updated to version 3.6.5, indicating a newer iteration of the page. This change updates the page’s revision record and does not modify the study details or data presented.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page revision was updated to v3.6.4, replacing the prior v3.6.3; this indicates a newer version of the page without altering core content.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.0. This indicates a software/content update without changes to study information.SummaryDifference0.0%

- Check94 days agoChange DetectedAdded a recruitment-status note 'No longer looking for participants', indicating enrollment is closed. Added navigation/help items including 'How to Read a Study Record', 'Common Questions', 'How to Join a Study', and 'Intervention/Treatment'.SummaryDifference0.2%

Stay in the know with updates to Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.